MediPharm Labs Provides Operational Update and Confirms Profitability Improvement Initiatives are Underway

3 years ago

Strong cash balance and continued reduction of convertible debt to less than $500K.Opportunities for optimization of the operating strategy between…

PharmaTher Provides Update on Product Pipeline and Expected Milestones for 2022

3 years ago

Focused on becoming a leader in the development and commercialization of specialty ketamine prescription-based products Expected milestones for 2022 include…

Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Density-Matched Interbody Cage

3 years ago

CARLSBAD, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…

ADMA Biologics Adopts Limited Duration Stockholder Rights Plan

3 years ago

RAMSEY, N.J. and BOCA RATON, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial…

LianBio Announces Infigratinib Approved Under Special Named Patient Program for the Treatment of Cholangiocarcinoma in the Pilot Zone of Hainan Province in China

3 years ago

SHANGHAI, China and PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing…

XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease

3 years ago

• Increased Xanthine Oxidase Expression in ADPKD Kidneys •CALGARY, Alberta, Dec. 21, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX"…

BioRestorative Therapies CEO Interviewing Live on the James Hicks NewMedia Show

3 years ago

MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company…

Samsung Bioepis Releases First Annual Sustainability Report

3 years ago

Outlines the company’s Environment, Social and Governance (ESG) performance and commitment to becoming a socially responsible and sustainable companyAppoints dedicated…

Helsinn Group Announces European Medicines Agency’s (EMA) Acceptance for review of the Marketing Authorization Application (MAA) for Infigratinib for Patients with Cholangiocarcinoma with Fibroblast Growth Factor Receptor 2 Fusions or Rearr

3 years ago

Helsinn Group Announces European Medicines Agency’s (EMA) Acceptance for review of the Marketing Authorization Application (MAA) for Infigratinib for Patients…

AirPhysio OPEP For Asthma – Airway Cleaning Natural Symptom Management Relaunch

3 years ago

Life Wellness Healthcare, leading respiratory specialist suppliers, have announced a relaunch of the top-selling all-natural AirPhysio breathing device for individuals…